The U.S. Food and Drug Administration approved Novavax's Covid-19 vaccine with age restrictions after a six-week delay.

After a six-week long delay, The Food and Drug Administration (FDA) has finally approved a more traditional protein-based covid vaccine produced by pharmaceutical giant Novavax.

The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

Mexico halts Brazilian poultry imports after a bird flu outbreak, the U.S. FDA conditionally approves Novavax's COVID vaccine ...

Kennedy Jr., has severely restricted the use of the NovavaxCOVID-19 vaccine. The vaccine will now only be available to ...

China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...

COVID-19 vaccine in a letter to the company dated Friday. “Under this license, you are authorized to manufacture ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA's Marty Makary.

Capt. Ed Enos makes his living as a harbor pilot in Hawaii, clambering aboard arriving ships in the predawn hours and guiding ...

Libraries across the United States are cutting back on e-books, audiobooks and loan programs after the Trump administration ...